|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
blurred vision |
|
dizziness |
|
headache or lightheadedness |
|
nausea |
|
nervousness |
|
pounding, irregular, or fast heartbeat |
|
trouble in sleeping |
|
Burning, dryness, or stinging of nasal mucosa |
|
increase in nasal discharge |
|
sneezing |
|
Rebound congestion |
|
Allergic reaction or hypersensitivity |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Coronary artery disease |
|
Heart disease, including angina |
|
Hypertension |
|
Enlarged prostate |
|
Diabetes mellitus |
|
>> Glaucoma, narrow-angle, predisposition to |
|
Hyperthyroidism |
|
|
ADULT DOSE:
|
|
Decongestant, topical-
Intranasal, 1 to 3 drops or sprays of a 0.1% solution into each nostril every eight to ten hours as needed. |
|
MAXIMUM ADULT DOSE:
|
|
Maxiumum of 3 doses per day.
Note:
The nasal solution form of the medication is more effective and less likely to cause systemic absorption.Usual pediatric dose
Note: The 0.1% solutions are not recommended for use in children up to 12 years of age.
Decongestant, topical-
Children up to 2 years of age: Dosage must be individualized by physician.
Children 2 to 12 years of age: Intranasal, 2 or 3 drops or sprays of a 0.05% solution into each nostril every eight to ten hours as needed.
Children 12 years of age and older: See Usual adult and adolescent dose
Note: The following dosage guidelines are used for children up to 12 years of age, in Canada:
Children up to 6 years of age: Intranasal, 1 drop or spray of a 0.05% solution into each nostril every eight to ten hours as needed.
Children 6 to 12 years of age: Intranasal, 2 or 3 drops or sprays of a 0.05% solution into each nostril every eight to ten hours as needed.
Usual pediatric prescribing limits
Maximum of 3 doses per day. |
|
PEDIATRIC DOSE:
|
|
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
Maxiumum of 3 doses per day.
Note:
The nasal solution form of the medication is more effective and less likely to cause systemic absorption.Usual pediatric dose
Note: The 0.1% solutions are not recommended for use in children up to 12 years of age.
Decongestant, topical-
Children up to 2 years of age: Dosage must be individualized by physician.
Children 2 to 12 years of age: Intranasal, 2 or 3 drops or sprays of a 0.05% solution into each nostril every eight to ten hours as needed.
Children 12 years of age and older: See Usual adult and adolescent dose
Note: The following dosage guidelines are used for children up to 12 years of age, in Canada:
Children up to 6 years of age: Intranasal, 1 drop or spray of a 0.05% solution into each nostril every eight to ten hours as needed.
Children 6 to 12 years of age: Intranasal, 2 or 3 drops or sprays of a 0.05% solution into each nostril every eight to ten hours as needed.
Usual pediatric prescribing limits
Maximum of 3 doses per day. |
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|